Evaluating the diagnostic accuracy of dynamic CT transmural sign for T staging of gastric cancer compared to conventional CT criteria.
[BACKGROUND] To retrospectively evaluate the diagnostic performance of pre-procedural multidetector computed tomography (MDCT) using dynamic CT transmural (CTTM) criteria for T staging of gastric canc
APA
Lee B, Chung DJ, et al. (2025). Evaluating the diagnostic accuracy of dynamic CT transmural sign for T staging of gastric cancer compared to conventional CT criteria.. BMC medical imaging, 25(1), 179. https://doi.org/10.1186/s12880-025-01728-8
MLA
Lee B, et al.. "Evaluating the diagnostic accuracy of dynamic CT transmural sign for T staging of gastric cancer compared to conventional CT criteria.." BMC medical imaging, vol. 25, no. 1, 2025, pp. 179.
PMID
40399836
Abstract
[BACKGROUND] To retrospectively evaluate the diagnostic performance of pre-procedural multidetector computed tomography (MDCT) using dynamic CT transmural (CTTM) criteria for T staging of gastric cancer.
[METHODS] This retrospective study enrolled 116 patients who underwent three-phase dynamic MDCT and subsequently received endoscopic treatment or surgery. The positive CTTM sign was defined as a new diagnostic criterion for this study. Two radiologists independently reviewed the CT images, categorizing patients into five groups: T1b sm1, T1b sm2/3, T2, T3, and T4. The diagnostic performance of the new criterion was assessed against pathological results as the gold standard. Sensitivity, specificity, accuracy, and positive and negative predictive values for each T stage were compared to those of conventional CT.
[RESULTS] Dynamic CTTM criteria demonstrated higher overall diagnostic accuracy (Reviewer 1: 88.9%, Reviewer 2: 91.4%) for T staging compared to conventional CT criteria (75.9%). Reviewer 1 accurately staged T1b in 85.3% of patients, T2 in 87.7%, T3 in 94.1%, and T4 in 98.3%. Reviewer 2 achieved T1b accuracy of 87.9%, T2 of 89.2%, T3 of 94.9%, and T4 of 98.3%. The dynamic CTTM criteria effectively subdivided T1b into T1b sm1 (87.2% and 88.1%) and T1b sm2/3 (84.6% and 86.2%). Dynamic CTTM criteria exhibited higher under-staging rates, while conventional criteria showed higher over-staging rates.
[CONCLUSIONS] Dynamic CTTM criteria demonstrated superior accuracy in T staging of gastric cancer and reasonable effectiveness in subdividing T1b stages into T1b sm1 and T1b sm2/3.
[METHODS] This retrospective study enrolled 116 patients who underwent three-phase dynamic MDCT and subsequently received endoscopic treatment or surgery. The positive CTTM sign was defined as a new diagnostic criterion for this study. Two radiologists independently reviewed the CT images, categorizing patients into five groups: T1b sm1, T1b sm2/3, T2, T3, and T4. The diagnostic performance of the new criterion was assessed against pathological results as the gold standard. Sensitivity, specificity, accuracy, and positive and negative predictive values for each T stage were compared to those of conventional CT.
[RESULTS] Dynamic CTTM criteria demonstrated higher overall diagnostic accuracy (Reviewer 1: 88.9%, Reviewer 2: 91.4%) for T staging compared to conventional CT criteria (75.9%). Reviewer 1 accurately staged T1b in 85.3% of patients, T2 in 87.7%, T3 in 94.1%, and T4 in 98.3%. Reviewer 2 achieved T1b accuracy of 87.9%, T2 of 89.2%, T3 of 94.9%, and T4 of 98.3%. The dynamic CTTM criteria effectively subdivided T1b into T1b sm1 (87.2% and 88.1%) and T1b sm2/3 (84.6% and 86.2%). Dynamic CTTM criteria exhibited higher under-staging rates, while conventional criteria showed higher over-staging rates.
[CONCLUSIONS] Dynamic CTTM criteria demonstrated superior accuracy in T staging of gastric cancer and reasonable effectiveness in subdividing T1b stages into T1b sm1 and T1b sm2/3.
MeSH Terms
Humans; Stomach Neoplasms; Male; Female; Neoplasm Staging; Middle Aged; Retrospective Studies; Aged; Sensitivity and Specificity; Multidetector Computed Tomography; Adult; Aged, 80 and over; Tomography, X-Ray Computed
같은 제1저자의 인용 많은 논문 (5)
- Advanced breath analysis through hierarchical deep convolutional neural network for multi-cancer screening.
- Emerging roles of POLR2L of RNA polymerase II dynamics and disease mechanisms (Review).
- The Obesity Paradox in Hepatocellular Carcinoma: Insights from Continuous and Interaction-Based Analyses of Body Mass Index After Hepatic Resection.
- "Obesity Paradox" as a new insight from long-term survivors in pancreatic cancer patients.
- Prospects of late-stage development agents in the treatment of metabolic dysfunction-associated steatohepatitis.